<DOC>
	<DOCNO>NCT02199574</DOCNO>
	<brief_summary>The purpose study characterize pharmacokinetic ( PK ) profile single dose EXPAREL ( 133 mg/10 mL ) administer intraoperatively per normal infiltration prolong analgesia 12 adult subject undergo tonsillectomy without removal adenoid .</brief_summary>
	<brief_title>Pharmacokinetic Evaluation EXPAREL Adults Undergoing Tonsillectomy</brief_title>
	<detailed_description>Blood sample bupivacaine PK analysis obtain subject baseline ( within 30 minute prior EXPAREL infiltration ) , 15 minute , 30 minute , 1 , 2 , 4 , 8 , 12 , 24 , 36 , 48 , 72 hour begin EXPAREL infiltration , Day 7 .</detailed_description>
	<criteria>Male female , â‰¥18 year age Screening Visit . Subjects undergo tonsillectomy without removal adenoid . Able willing comply study visit procedure . Willing capable provide write informed consent . History hypersensitivity idiosyncratic reaction amidetype local anesthetic . Received investigational drug within 30 day prior EXPAREL administration , and/or plan administration another investigational product procedure participate study . Currently pregnant , nursing , plan become pregnant study within 1 month EXPAREL administration . Female subject must surgically sterile , least 2 year postmenopausal , use acceptable method birth control . If childbearing potential , must document negative pregnancy test within 24 hour EXPAREL administration . Subjects significant medical condition laboratory result , opinion Investigator , indicate increase vulnerability EXPAREL and/or procedure , cause inability comply study requirement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>